Trial Outcomes & Findings for Clinical Study for TONOREF III Tested to ANSI Z80.10-2014 (NCT NCT07152808)

NCT ID: NCT07152808

Last Updated: 2026-04-24

Results Overview

Agreement of the measured IOP between the test device and the predicate device (GAT) for the tonometer function of the TONOREF III. (Agreement means the similarity of results when measurements from the test device and the predicate device are compared against each other.)

Recruitment status

COMPLETED

Target enrollment

52 participants

Primary outcome timeframe

1-2 study visits per subject over the course of 8 days

Results posted on

2026-04-24

Participant Flow

Participant milestones

Participant milestones
Measure
TONOREF III and Goldmann Tonometer Measurements
Subjects will undergo IOP measurements using both the investigational device (TONOREF III) and the predicate device (Goldmann Applanation Tonometer). NIDEK TONOREF III: The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye. Haag-Streit Goldmann Manual Tonometer: Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma
Overall Study
STARTED
52
Overall Study
COMPLETED
42
Overall Study
NOT COMPLETED
10

Reasons for withdrawal

Reasons for withdrawal
Measure
TONOREF III and Goldmann Tonometer Measurements
Subjects will undergo IOP measurements using both the investigational device (TONOREF III) and the predicate device (Goldmann Applanation Tonometer). NIDEK TONOREF III: The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye. Haag-Streit Goldmann Manual Tonometer: Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma
Overall Study
screening failure
10

Baseline Characteristics

Clinical Study for TONOREF III Tested to ANSI Z80.10-2014

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
TONOREF III and Goldmann Tonometer Measurements
n=42 Participants
Subjects will undergo IOP measurements using both the investigational device (TONOREF III) and the predicate device (Goldmann Applanation Tonometer). NIDEK TONOREF III: The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye. Haag-Streit Goldmann Manual Tonometer: Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma
Race (NIH/OMB)
Black or African American
5 Participants
n=2 Participants
Age, Continuous
64.6 years
STANDARD_DEVIATION 12.74 • n=2 Participants
Sex: Female, Male
Female
24 Participants
n=2 Participants
Sex: Female, Male
Male
18 Participants
n=2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=2 Participants
Race (NIH/OMB)
Asian
0 Participants
n=2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=2 Participants
Race (NIH/OMB)
White
37 Participants
n=2 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=2 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=2 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
42 Participants
n=2 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=2 Participants

PRIMARY outcome

Timeframe: 1-2 study visits per subject over the course of 8 days

Agreement of the measured IOP between the test device and the predicate device (GAT) for the tonometer function of the TONOREF III. (Agreement means the similarity of results when measurements from the test device and the predicate device are compared against each other.)

Outcome measures

Outcome measures
Measure
TONOREF III and Goldmann Tonometer Measurements
n=80 eyes
Subjects will undergo IOP measurements using both the investigational device (TONOREF III) and the predicate device (Goldmann Applanation Tonometer). NIDEK TONOREF III: The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye. Haag-Streit Goldmann Manual Tonometer: Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma
Agreement of Intraocular Pressure
NIDEK TONOREF III
18.4 mmHg
Standard Deviation 4.50
Agreement of Intraocular Pressure
Haag-Streit GAT
18.3 mmHg
Standard Deviation 5.11

SECONDARY outcome

Timeframe: 1-2 study visits per subject over the course of 8 days

Population: No subject had an AE.

To demonstrate that the test device is as safe as GAT

Outcome measures

Outcome measures
Measure
TONOREF III and Goldmann Tonometer Measurements
n=52 Participants
Subjects will undergo IOP measurements using both the investigational device (TONOREF III) and the predicate device (Goldmann Applanation Tonometer). NIDEK TONOREF III: The auto ref/kerato/tono/pachymeter TONOREF III is a medical device which measures objective refractive errors, corneal curvature radius, intraocular pressure and corneal thickness of the patient's eye. Haag-Streit Goldmann Manual Tonometer: Haag-Streit Goldmann Manual Tonometer measures intraocular pressure to aid in the screening and diagnosis of glaucoma
The Numbers of Adverse Events
0 Number of Adverse Event

Adverse Events

TONOREF III and Goldmann Tonometer Measurements

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Tadakazu Ichimura

NIDEK CO., LTD.

Phone: +81-533-67-8904

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place